SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001171843-18-006965
Filing Date
2018-10-12
Accepted
2018-10-12 17:05:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM posam_101218.htm POS AM 302832
2 EXHIBIT 23.1 exh_231.htm EX-23.1 3729
3 GRAPHIC kpmg.jpg GRAPHIC 5097
4 GRAPHIC acasti.jpg GRAPHIC 9594
  Complete submission text file 0001171843-18-006965.txt   328030
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: POS AM | Act: 33 | File No.: 333-220755 | Film No.: 181120768
SIC: 2834 Pharmaceutical Preparations